Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of Tris Pharma patents

Patents where

Current Assignee

Name

‌

Tris Pharma

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11337919 Modified release drug powder composition comprising gastro-retentive RAFT forming systems having trigger pulse drug release	Patent 11337919 was granted and assigned to Tris Pharma on May, 2022 by the United States Patent and Trademark Office.	‌ Tris Pharma	‌ Tris Pharma	United States Patent and Trademark Office	11337919	May 24, 2022
‌ US Patent 9180104 Benzonatate modified release solid tablets and capsules	Patent 9180104 was granted and assigned to Tris Pharma on November, 2015 by the United States Patent and Trademark Office.	‌ Tris Pharma	‌ Tris Pharma	United States Patent and Trademark Office	9180104	November 10, 2015
‌ US Patent 11337920 Pharmaceutical composition comprising GHB gastro-retentive raft forming systems having trigger pulse drug release	Patent 11337920 was granted and assigned to Tris Pharma on May, 2022 by the United States Patent and Trademark Office.	‌ Tris Pharma	‌ Tris Pharma	United States Patent and Trademark Office	11337920	May 24, 2022
‌ US Patent 8956649 Orally effective methylphenidate extended release powder and aqueous suspension product	Patent 8956649 was granted and assigned to Tris Pharma on February, 2015 by the United States Patent and Trademark Office.	‌ Tris Pharma	‌ Tris Pharma	United States Patent and Trademark Office	8956649	February 17, 2015
‌ US Patent 8465765 Orally effective methylphenidate extended release powder and aqueous suspension product	Patent 8465765 was granted and assigned to Tris Pharma on June, 2013 by the United States Patent and Trademark Office.		‌ Tris Pharma	United States Patent and Trademark Office	8465765	June 18, 2013
‌ US Patent 9040083 Orally effective methylphenidate extended release powder and aqueous suspension product	Patent 9040083 was granted and assigned to Tris Pharma on May, 2015 by the United States Patent and Trademark Office.	‌ Tris Pharma	‌ Tris Pharma	United States Patent and Trademark Office	9040083	May 26, 2015
‌ US Patent 8623409 Clonidine formulation	Patent 8623409 was granted and assigned to Tris Pharma on January, 2014 by the United States Patent and Trademark Office.		‌ Tris Pharma	United States Patent and Trademark Office	8623409	January 7, 2014
‌ US Patent 9198864 Modified release formulations containing drug-ion exchange resin complexes	Patent 9198864 was granted and assigned to Tris Pharma on December, 2015 by the United States Patent and Trademark Office.	‌ Tris Pharma	‌ Tris Pharma	United States Patent and Trademark Office	9198864	December 1, 2015
‌ US Patent 9545399 Methylphenidate extended release chewable tablet	Patent 9545399 was granted and assigned to Tris Pharma on January, 2017 by the United States Patent and Trademark Office.	‌ Tris Pharma	‌ Tris Pharma	United States Patent and Trademark Office	9545399	January 17, 2017
‌ US Patent 10507203 Methylphenidate extended release chewable tablet	Patent 10507203 was granted and assigned to Tris Pharma on December, 2019 by the United States Patent and Trademark Office.	‌ Tris Pharma	‌ Tris Pharma	United States Patent and Trademark Office	10507203	December 17, 2019
‌ US Patent 9295642 Methylphenidate extended release chewable tablet	Patent 9295642 was granted and assigned to Tris Pharma on March, 2016 by the United States Patent and Trademark Office.	‌ Tris Pharma	‌ Tris Pharma	United States Patent and Trademark Office	9295642	March 29, 2016
‌ US Patent 8999386 Methylphenidate extended release chewable tablet	Patent 8999386 was granted and assigned to Tris Pharma on April, 2015 by the United States Patent and Trademark Office.	‌ Tris Pharma	‌ Tris Pharma	United States Patent and Trademark Office	8999386	April 7, 2015
‌ US Patent 8202537 Modified release formulations containing drug-ion exchange resin complexes	Patent 8202537 was granted and assigned to Tris Pharma on June, 2012 by the United States Patent and Trademark Office.		‌ Tris Pharma	United States Patent and Trademark Office	8202537	June 19, 2012
‌ US Patent 9844544 Methylphenidate extended release chewable tablet	Patent 9844544 was granted and assigned to Tris Pharma on December, 2017 by the United States Patent and Trademark Office.	‌ Tris Pharma	‌ Tris Pharma	United States Patent and Trademark Office	9844544	December 19, 2017
‌ US Patent 9408823 Benzonatate modified release solid tablets and capsules	Patent 9408823 was granted and assigned to Tris Pharma on August, 2016 by the United States Patent and Trademark Office.	‌ Tris Pharma	‌ Tris Pharma	United States Patent and Trademark Office	9408823	August 9, 2016
‌ US Patent 9844545 Methylphenidate extended release chewable tablet	Patent 9844545 was granted and assigned to Tris Pharma on December, 2017 by the United States Patent and Trademark Office.	‌ Tris Pharma	‌ Tris Pharma	United States Patent and Trademark Office	9844545	December 19, 2017
‌ US Patent 11590228 Extended release amphetamine compositions	Patent 11590228 was granted and assigned to Tris Pharma on February, 2023 by the United States Patent and Trademark Office.	‌ Tris Pharma	‌ Tris Pharma	United States Patent and Trademark Office	11590228	February 28, 2023
‌ US Patent 9180100 Methylphenidate extended release chewable tablet	Patent 9180100 was granted and assigned to Tris Pharma on November, 2015 by the United States Patent and Trademark Office.	‌ Tris Pharma	‌ Tris Pharma	United States Patent and Trademark Office	9180100	November 10, 2015
‌ US Patent 9867797 Benzonatate modified release solid tablets and capsules	Patent 9867797 was granted and assigned to Tris Pharma on January, 2018 by the United States Patent and Trademark Office.	‌ Tris Pharma	‌ Tris Pharma	United States Patent and Trademark Office	9867797	January 16, 2018
‌ US Patent 11590081 Extended release amphetamine tablets	Patent 11590081 was granted and assigned to Tris Pharma on February, 2023 by the United States Patent and Trademark Office.	‌ Tris Pharma	‌ Tris Pharma	United States Patent and Trademark Office	11590081	February 28, 2023
‌ US Patent 10933143 Modified release formulations containing drug-ion exchange resin complexes	Patent 10933143 was granted and assigned to Tris Pharma on March, 2021 by the United States Patent and Trademark Office.	‌ Tris Pharma	‌ Tris Pharma	United States Patent and Trademark Office	10933143	March 2, 2021
‌ US Patent 10172958 Modified release formulations containing drug-ion exchange resin complexes	Patent 10172958 was granted and assigned to Tris Pharma on January, 2019 by the United States Patent and Trademark Office.	‌ Tris Pharma	‌ Tris Pharma	United States Patent and Trademark Office	10172958	January 8, 2019
‌ US Patent 11633389 Methylphenidate extended release chewable tablet	Patent 11633389 was granted and assigned to Tris Pharma on April, 2023 by the United States Patent and Trademark Office.	‌ Tris Pharma	‌ Tris Pharma	United States Patent and Trademark Office	11633389	April 25, 2023
‌ US Patent 8062667 Modified release formulations containing drug-ion exchange resin complexes	Patent 8062667 was granted and assigned to Tris Pharma on November, 2011 by the United States Patent and Trademark Office.		‌ Tris Pharma	United States Patent and Trademark Office	8062667	November 22, 2011
‌ US Patent 11103494 Methylphenidate extended release chewable tablet	Patent 11103494 was granted and assigned to Tris Pharma on August, 2021 by the United States Patent and Trademark Office.	‌ Tris Pharma	‌ Tris Pharma	United States Patent and Trademark Office	11103494	August 31, 2021

Results per page:

52 results

0 selected

52 results

0 selected